MTORC1-Regulated Metabolism Controlled by TSC2 Limits Cardiac Reperfusion Injury

• Published in: Circulation research 2021-03, Vol.128 (5), p.639-651
• Main Authors: Oeing, Christian U., Jun, Seungho, Mishra, Sumita, Dunkerly-Eyring, Brittany L., Chen, Anna, Grajeda, Maria I., Tahir, Usman A., Gerszten, Robert E., Paolocci, Nazareno, Ranek, Mark J., Kass, David A.
• Format: Article
• Language: English
• Subjects: Animals; Carnitine - analogs & derivatives; Carnitine - metabolism; Cells, Cultured; Glucose - metabolism; Glycolysis; Ischemic Preconditioning; Lactic Acid - metabolism; Male; Mechanistic Target of Rapamycin Complex 1 - metabolism; Mice; Mice, Inbred C57BL; Mitochondria, Heart - metabolism; Mutation; Myocardial Reperfusion Injury - metabolism; Myocardial Reperfusion Injury - therapy; Myocytes, Cardiac - metabolism; Oxygen - metabolism; Phosphorylation; Rats; Tuberous Sclerosis Complex 2 Protein - genetics; Tuberous Sclerosis Complex 2 Protein - metabolism
• ISSN: 0009-7330; 1524-4571
• DOI: 10.1161/CIRCRESAHA.120.317710

The mTORC1 (mechanistic target of rapamycin complex-1) controls metabolism and protein homeostasis and is activated following ischemia reperfusion (IR) injury and by ischemic preconditioning (IPC). However, studies vary as to whether this activation is beneficial or detrimental, and its influence on metabolism after IR is little reported. A limitation of prior investigations is their use of broad gain/loss of mTORC1 function, mostly applied before ischemic stress. This can be circumvented by regulating one serine (S1365) on TSC2 (tuberous sclerosis complex) to achieve bidirectional mTORC1 modulation but only with TCS2-regulated costimulation. We tested the hypothesis that reduced TSC2 S1365 phosphorylation protects the myocardium against IR and is required for IPC by amplifying mTORC1 activity to favor glycolytic metabolism. Mice with either S1365A (TSC2 ; phospho-null) or S1365E (TSC2 ; phosphomimetic) knockin mutations were studied ex vivo and in vivo. In response to IR, hearts from TSC2 mice had amplified mTORC1 activation and improved heart function compared with wild-type and TSC2 hearts. The magnitude of protection matched IPC. IPC requited less S1365 phosphorylation, as TSC2 hearts gained no benefit and failed to activate mTORC1 with IPC. IR metabolism was altered in TSC2 , with increased mitochondrial oxygen consumption rate and glycolytic capacity (stressed/maximal extracellular acidification) after myocyte hypoxia-reperfusion. In whole heart, lactate increased and long-chain acylcarnitine levels declined during ischemia. The relative IR protection in TSC2 was lost by lowering glucose in the perfusate by 36%. Adding fatty acid (palmitate) compensated for reduced glucose in wild type and TSC2 but not TSC2 which had the worst post-IR function under these conditions. TSC2-S1365 phosphorylation status regulates myocardial substrate utilization, and its decline activates mTORC1 biasing metabolism away from fatty acid oxidation to glycolysis to confer protection against IR. This pathway is also engaged and reduced TSC2 S1365 phosphorylation required for effective IPC. Graphic Abstract: A graphic abstract is available for this article.